895 related articles for article (PubMed ID: 25693568)
1. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
[TBL] [Abstract][Full Text] [Related]
2. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
4. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
Tansey KE; Cameron D; Hill MJ
Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration.
Alcalà-Vida R; Awada A; Boutillier AL; Merienne K
Neurobiol Dis; 2021 Jan; 147():105155. PubMed ID: 33127472
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
[TBL] [Abstract][Full Text] [Related]
7. Epigenomics: Roadmap for regulation.
Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G
Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562
[No Abstract] [Full Text] [Related]
8. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.
Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL
Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316
[TBL] [Abstract][Full Text] [Related]
9. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.
Huang KL; Marcora E; Pimenova AA; Di Narzo AF; Kapoor M; Jin SC; Harari O; Bertelsen S; Fairfax BP; Czajkowski J; Chouraki V; Grenier-Boley B; Bellenguez C; Deming Y; McKenzie A; Raj T; Renton AE; Budde J; Smith A; Fitzpatrick A; Bis JC; DeStefano A; Adams HHH; Ikram MA; van der Lee S; Del-Aguila JL; Fernandez MV; Ibañez L; ; ; Sims R; Escott-Price V; Mayeux R; Haines JL; Farrer LA; Pericak-Vance MA; Lambert JC; van Duijn C; Launer L; Seshadri S; Williams J; Amouyel P; Schellenberg GD; Zhang B; Borecki I; Kauwe JSK; Cruchaga C; Hao K; Goate AM
Nat Neurosci; 2017 Aug; 20(8):1052-1061. PubMed ID: 28628103
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease Variants with the Genome-Wide Significance are Significantly Enriched in Immune Pathways and Active in Immune Cells.
Jiang Q; Jin S; Jiang Y; Liao M; Feng R; Zhang L; Liu G; Hao J
Mol Neurobiol; 2017 Jan; 54(1):594-600. PubMed ID: 26746668
[TBL] [Abstract][Full Text] [Related]
11. Systems Genetics in Human Endothelial Cells Identifies Non-coding Variants Modifying Enhancers, Expression, and Complex Disease Traits.
Stolze LK; Conklin AC; Whalen MB; López Rodríguez M; Õunap K; Selvarajan I; Toropainen A; Örd T; Li J; Eshghi A; Solomon AE; Fang Y; Kaikkonen MU; Romanoski CE
Am J Hum Genet; 2020 Jun; 106(6):748-763. PubMed ID: 32442411
[TBL] [Abstract][Full Text] [Related]
12. PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
Sanchez-Mut JV; Heyn H; Silva BA; Dixsaut L; Garcia-Esparcia P; Vidal E; Sayols S; Glauser L; Monteagudo-Sánchez A; Perez-Tur J; Ferrer I; Monk D; Schneider B; Esteller M; Gräff J
Nat Med; 2018 May; 24(5):598-603. PubMed ID: 29736028
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
14. Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.
Yokoyama JS; Wang Y; Schork AJ; Thompson WK; Karch CM; Cruchaga C; McEvoy LK; Witoelar A; Chen CH; Holland D; Brewer JB; Franke A; Dillon WP; Wilson DM; Mukherjee P; Hess CP; Miller Z; Bonham LW; Shen J; Rabinovici GD; Rosen HJ; Miller BL; Hyman BT; Schellenberg GD; Karlsen TH; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2016 Jun; 73(6):691-7. PubMed ID: 27088644
[TBL] [Abstract][Full Text] [Related]
15. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
16. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
[TBL] [Abstract][Full Text] [Related]
17. Chromosome conformation elucidates regulatory relationships in developing human brain.
Won H; de la Torre-Ubieta L; Stein JL; Parikshak NN; Huang J; Opland CK; Gandal MJ; Sutton GJ; Hormozdiari F; Lu D; Lee C; Eskin E; Voineagu I; Ernst J; Geschwind DH
Nature; 2016 Oct; 538(7626):523-527. PubMed ID: 27760116
[TBL] [Abstract][Full Text] [Related]
18. Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system.
Fominykh V; Shadrin AA; Jaholkowski PP; Bahrami S; Athanasiu L; Wightman DP; Uffelmann E; Posthuma D; Selbæk G; Dale AM; Djurovic S; Frei O; Andreassen OA
Neurobiol Dis; 2023 Jul; 183():106174. PubMed ID: 37286172
[TBL] [Abstract][Full Text] [Related]
19. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.
Klein HU; Bennett DA; De Jager PL
Acta Neuropathol; 2016 Oct; 132(4):503-14. PubMed ID: 27573688
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline.
Berchtold NC; Prieto GA; Phelan M; Gillen DL; Baldi P; Bennett DA; Buchman AS; Cotman CW
Neurobiol Aging; 2019 Jun; 78():142-154. PubMed ID: 30927700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
